Aurion Biotech, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
Aurion Biotech, a clinical-stage biotech firm, is seeking an IPO to advance its regenerative therapies for corneal endothelial diseases, including its lead candidate AURN001.